Morning Overview on MSN
Simple blood test could predict dementia risk in overlooked Latin Americans
Researchers have evaluated a simple blood test measuring plasma p-tau217 in nearly 600 Latin Americans across six countries, adding large-scale evidence that a potentially lower-cost screening tool ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
A protein lurking around in the blood can help with the accurate diagnosis of Alzheimer's disease. In a recent study, researchers from Spain investigated how blood-based biomarkers, such as a protein ...
A single protein in your blood can rise for years before Alzheimer’s symptoms appear. In a new study, researchers argue that ...
Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...
Researchers have identified a new type of blood-based biomarker test for Alzheimer's disease that measures structural changes in proteins, providing more information on the underlying biology of the ...
New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA, Mass.--(BUSINESS WIRE)--Lucent ...
Add Yahoo as a preferred source to see more of our stories on Google. Roche's Elecsys pTau181 test is the second blood-based biomarker test to receive FDA clearance for Alzheimer’s disease this year. ...
In a recent study published in the journal Nature Medicine, researchers in Sweden and the United States assessed whether a brief self-administered digital cognitive battery, alone or combined with a ...
Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a precision diagnostics company, today announced that it has in-licensed from ...
Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...
TORONTO, July 29, 2025 /PRNewswire/ -- In a landmark step toward transforming Alzheimer's disease diagnosis in specialty care, the Alzheimer's Association today released its first clinical practice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results